| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |